Dietary GABA and its combination with vigabatrin mimic calorie restriction and induce antiobesity-like effects in lean mice
The anti-obesity and anti-diabetic effects of γ-aminobutyric acid (GABA) are mainly expressed via glucose and insulin regulation in mice. It is unknown whether dietary GABA exerts anti-obesity effects via other pathways. Herein, we report that a high dietary GABA intake (5%) significantly suppressed...
Main Authors: | Kanako Sato, Takumi Komaru, Takeshi Arima, Chanakarn Jardson, Noriyuki Yanaka, Thanutchaporn Kumrungsee |
---|---|
Format: | Article |
Language: | English |
Published: |
Elsevier
2021-03-01
|
Series: | Journal of Functional Foods |
Subjects: | |
Online Access: | http://www.sciencedirect.com/science/article/pii/S1756464621000165 |
Similar Items
-
Vigabatrin induced Cell loss in the Cerebellar Cortex of Albino Rats
by: Deepa Singh, et al.
Published: (2013-11-01) -
Role of nitric oxide synthase on brain GABA transaminase activity and GABA levels
by: Vega Rasgado Lourdes A., et al.
Published: (2018-09-01) -
A critical role of hepatic GABA in the metabolic dysfunction and hyperphagia of obesity
by: Caroline E. Geisler, et al.
Published: (2021-06-01) -
Preclinical tissue distribution and metabolic correlations of vigabatrin, an antiepileptic drug associated with potential use‐limiting visual field defects
by: Dana C. Walters, et al.
Published: (2019-02-01) -
Hepatocyte membrane potential regulates serum insulin and insulin sensitivity by altering hepatic GABA release
by: Caroline E. Geisler, et al.
Published: (2021-06-01)